Characterization and oncolytic virus targeting of FAP-expressing tumor-associated pericytes in glioblastoma
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2051-5960
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Characterization and oncolytic virus targeting of FAP-expressing tumor-associated pericytes in glioblastoma ; volume:8 ; number:1 ; day:11 ; month:12 ; year:2020 ; pages:1-13 ; date:12.2020
Acta Neuropathologica Communications ; 8, Heft 1 (11.12.2020), 1-13, 12.2020
- Creator
-
Li, Ming
Li, Guoping
Kiyokawa, Juri
Tirmizi, Zain
Richardson, Leland G.
Ning, Jianfang
Das, Saumya
Martuza, Robert L.
Stemmer-Rachamimov, Anat
Rabkin, Samuel D.
Wakimoto, Hiroaki
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s40478-020-01096-0
- URN
-
urn:nbn:de:101:1-2021011819331043055150
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:36 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Li, Ming
- Li, Guoping
- Kiyokawa, Juri
- Tirmizi, Zain
- Richardson, Leland G.
- Ning, Jianfang
- Das, Saumya
- Martuza, Robert L.
- Stemmer-Rachamimov, Anat
- Rabkin, Samuel D.
- Wakimoto, Hiroaki
- SpringerLink (Online service)
Other Objects (12)
Oncolytic virus and tumor-associated macrophage interactions in cancer immunotherapy
Oncolytic adenoviruses expressing checkpoint inhibitors for cancer therapy
Lineage-tracing reveals the genesis of pericytes from Nestin expressing cells during glioma angiogenesis
Effects of stem cell transcription factor-expressing vaccinia viruses in oncolytic virotherapy
Effects of stem cell transcription factor-expressing vaccinia viruses in oncolytic virotherapy
Generation of an Oncolytic Herpes Simplex Virus 1 Expressing Human MelanA
Oncolytic adenovirus expressing bispecific antibody targets T‐cell cytotoxicity in cancer biopsies
FAP
FAP
Carcinoembryonic antigen-expressing oncolytic measles virus derivative in recurrent glioblastoma: a phase 1 trial
Advances and potential pitfalls of oncolytic viruses expressing immunomodulatory transgene therapy for malignant gliomas
Treatment of medulloblastoma with oncolytic measles viruses expressing the angiogenesis inhibitors endostatin and angiostatin
Oncolytic virus and tumor-associated macrophage interactions in cancer immunotherapy
Oncolytic adenoviruses expressing checkpoint inhibitors for cancer therapy
Lineage-tracing reveals the genesis of pericytes from Nestin expressing cells during glioma angiogenesis
Effects of stem cell transcription factor-expressing vaccinia viruses in oncolytic virotherapy
Effects of stem cell transcription factor-expressing vaccinia viruses in oncolytic virotherapy
Generation of an Oncolytic Herpes Simplex Virus 1 Expressing Human MelanA
Oncolytic adenovirus expressing bispecific antibody targets T‐cell cytotoxicity in cancer biopsies
FAP
FAP
Carcinoembryonic antigen-expressing oncolytic measles virus derivative in recurrent glioblastoma: a phase 1 trial
Advances and potential pitfalls of oncolytic viruses expressing immunomodulatory transgene therapy for malignant gliomas
Treatment of medulloblastoma with oncolytic measles viruses expressing the angiogenesis inhibitors endostatin and angiostatin
Oncolytic virus and tumor-associated macrophage interactions in cancer immunotherapy
Oncolytic adenoviruses expressing checkpoint inhibitors for cancer therapy
Lineage-tracing reveals the genesis of pericytes from Nestin expressing cells during glioma angiogenesis
Effects of stem cell transcription factor-expressing vaccinia viruses in oncolytic virotherapy
Effects of stem cell transcription factor-expressing vaccinia viruses in oncolytic virotherapy
Generation of an Oncolytic Herpes Simplex Virus 1 Expressing Human MelanA
Oncolytic adenovirus expressing bispecific antibody targets T‐cell cytotoxicity in cancer biopsies
FAP
FAP
Carcinoembryonic antigen-expressing oncolytic measles virus derivative in recurrent glioblastoma: a phase 1 trial
Advances and potential pitfalls of oncolytic viruses expressing immunomodulatory transgene therapy for malignant gliomas